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medial temporal lobe atrophy (MTA) could account for differences in cognitive domains affected.
Methods: In 329 patients with AD, we assessed five cognitive domains: memory, language, visuo-
spatial functioning, executive functioning, and attention. Magnetic resonance imaging (MRI) was
rated visually for the presence of MTA and PA. Two-way analyses of variance were performed
with MTA and PA as independent variables, and cognitive domains as dependent variables. Gender,
age, and education were covariates. As PA is often encountered in younger patients, analyses were
repeated after stratification for age of onset (early onset,  65 years).
Results: The mean age of the participants was 67 years, 175 (53%) were female, and the meanMini-
Mental State Examination (score 6 standard deviation) was 20 6 5 points. Based on dichotomized
magnetic resonance imaging ratings, 84 patients (26%) had MTA and PA, 98 (30%) had MTA, 57
(17%) had PA, and 90 (27%) had neither. MTAwas associated with worse performance on memory,
language, and attention (all, P, .05), and PAwas associated with worse performance on visuospatial
and executive functioning (both, P, .05). Stratification for age showed in patients with late-onset AD
(n 5 173) associations between MTA and impairment on memory, language, visuospatial function-
ing, and attention (all, P , .05); in early-onset AD (n 5 156), patients with PA tended to perform
worse on visuospatial functioning.
Conclusions: Regional atrophy is related to impairment in specific cognitive domains in AD. The
prevalence of PA in a large set of patients with AD and its association with cognitive functioning
provides support for the usefulness of this visual rating scale in the diagnostic evaluation of AD.
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Alzheimer’s disease (AD) is increasingly considered
a heterogeneous disease that may present initially with cog-
nitive decline other than pronounced memory impairment
[1–3]. Besides memory impairment, AD may also featurethor. Tel.: 131 20 4440685; Fax: 131 20 4440715.
mits@vumc.nl
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16/j.jalz.2013.06.007nonamnestic presentations with prominent dysfunction in
language, visuospatial functions, or executive functions.
These atypical presentations are also recognized in the
new clinical criteria for AD [4].
On magnetic resonance imaging (MRI), atrophy of the
medial temporal lobe, especially the hippocampus, is consid-
ered a diagnostic hallmark of AD, and relations with episodic
memory impairment have been shown frequently [5–7].
Medial temporal lobe atrophy (MTA) can be scored usingeserved.
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episodicmemory and iswidely used in clinical practice [7–9].
Nevertheless, not every patient with AD presents with
MTA. Imaging studies have revealed prominent (fronto-)pa-
rietal atrophy in AD, especially in patients with an earlier
age of onset [10–12]. Patients with posterior cortical
atrophy (PCA) form a distinct subgroup, presenting with
prominent visual problems, but posterior atrophy (PA)
seems to be far more frequent in AD [13]. Recently, we
developed a new visual rating scale for PA that allows for
easy use in clinical practice [14,15]. It has been shown that
PA discriminates early-onset patients with AD from younger
control subjects independent of MTA [15]. It is attractive to
assume that this scale is associated with cognitive impair-
ment in AD, especially nonamnestic signs and symptoms,
but this has not yet been proved.
In the current study, we therefore assessed associations
between visual ratings of MTA and PA and cognitive impair-
ment in a large set of patients with AD. In addition, we strat-
ified the analyses at age of onset, because PA is observed
relatively often in early-onset AD.2. Methods
2.1. Subjects
Consecutive patients (n 5 344) with probable AD were
included from the outpatient memory clinic of the Alzheimer
Center of the VU University Medical Center (VUmc) be-
tweenAugust 2008 and January 2012. For the diagnostic pro-
cedure, all patients underwent a standardized 1-day
assessment, including medical history and family history
for dementia, informant-based history, physical and neuro-
logical examinations, neuropsychological assessment, labo-
ratory tests, electroencephalogram, and MRI of the brain.
Diagnoses were made in amultidisciplinary consensus meet-
ing.All patients fulfilled the core clinical criteria for probable
AD of the National Institute on Aging–Alzheimer’s Associ-
ation [4]. Inclusion criteria for this study were a diagnosis of
probable AD and available Mini-Mental State Examination
(MMSE) score, Cambridge Cognitive Examination (CAM-
COG) score, and neuropsychological assessment. Exclusion
criteria were frank vascular abnormalities (n5 10) andmiss-
ingMRI sequences (n5 5). This resulted in a total study sam-
ple of 329 patients. Level of education was classified
according to the system of Verhage, ranging from 1 to 7
points (low to highly educated) [16]. The study was conduct-
ed in accordance with regional research regulations and con-
formed to the Declaration of Helsinki. The local medical
ethics committee approved the study, and all patients gave
written informed consent for their clinical data to be used
for research purposes.
2.2. Neuropsychological assessment
Cognitive functions were assessed with a standardized
test battery, covering several cognitive domains. We usedthe MMSE and the CAMCOG for global cognitive decline
[17,18]. For memory, we used the Visual Association Test
(VAT), and total immediate recall and delayed recall of the
Dutch version of the Rey Auditory Verbal Learning Task
(RAVLT) [19–21]. To examine language, we used VAT
naming, category fluency (animals), and the Dutch version
of the Controlled Oral Word Association Test (letter
fluency) [19,22,23]. We used three subtests of the Visual
Object and Space Perception Battery to assess visuospatial
functioning—namely, incomplete letters, dot counting, and
number location [24]. For the attention domain we used Trail
Making Test (TMT) A and the forward condition of digit
span (extended version) [25,26]. We used TMT B and the
backward condition of digit span (extended version) to
examine executive functioning [25,26].2.3. MRI and image analysis
MRI was performed on a 3.0-T magnetic resonance
system (Signa HDxt; General Electric, Milwaukee, WI).
All subjects were examined according to a standard demen-
tia MRI protocol, including sagittal, T1-weighted three-
dimensional (3D) fast spoiled gradient echo sequences (field
of view [FOV], 25 cm; matrix, 256 ! 256; 1-mm slices;
echo time, 3 ms; repetition time, 7.8 ms; inversion
time, 450 ms; one signal acquired), 3D fluid-attenuated in-
version recovery (FLAIR) sequences (FOV, 25 cm; ma-
trix, 224 ! 224; 1.2-mm slices; echo time, 140 ms;
repetition time, 8000ms; inversion time, 2349ms; echo train
length, 230; one signal acquired), and axial fast spin-echo
T2/PD (Proton Density) sequences (FOV, 25 cm; matrix, 384
! 384; 3-mm slices; echo time, 23/114 ms; repetition
time, 9100 ms; echo train length, 24; two signals acquired).
Multiplanar reconstructions of 3D T1-weighted sequences
were performed in sagittal (5 mm) and oblique–coronal ori-
entations (3-mm slices perpendicular to the long axis of the
hippocampus). Multiplanar reconstructions of 3D FLAIR
images were performed in transverse orientation using
a 3-mm section thickness.
The image analysis included a visual rating of MTA and
PA [8,14]. T1-weighted images were viewed in the coronal
plane, and MTA scores for the left and right hemispheres
were given. The scale rates atrophy on a 5-point scale
(0 point, absent; 1 point, minimal; 2 points, mild;
3 points, moderate; and 4 points, severe) based on the height
of the hippocampal formation and the width of the choroid
fissure and the temporal horn [8]. PA scoring was based
on the axial multiplanar reconstruction of the FLAIR
sequences, and the coronal and sagittal reconstructions of
the 3D T1-weighted sequence. The PA scale rates atrophy
on a 4-point scale (0 point, absent; 1 point, mild sulcal wid-
ening and mild atrophy; 2 points, substantial widening and
substantial atrophy; and 3 points, end-stage atrophy) based
on the posterior cingulate- and parieto-occipital sulcus and
sulci of the parietal lobes and precuneus [14]. MTA and
PA scores were dichotomized into relevant atrophy present
Table 1
Demographics and pooled neuropsychological test performance of patients with or without MTA or PA
Characteristic All patients
MTA PA
No atrophy Atrophy No atrophy Atrophy
n 329 147 182 188 141
Women, n (%) 175 (53) 84 (57) 92 (50) 103 (54) 73 (52)
Age, y; mean 6 SD 67 6 8 65 6 7 69 6 8* 67 6 7 66 6 9
Level of education, mean 6 SDy 5 6 1 5 6 1 5 6 1 5 6 1 5 6 1*
MMSE score, pt; mean 6 SD 20 6 5 20 6 5 19 6 6 20 6 5 20 6 5
CAMCOG score, pt; mean 6 SD 66 6 17 68 6 15 64 6 18* 67 6 17 65 6 17
Memory score, pt; mean 6 SD
VAT 5 6 4 6 6 4 5 6 4 5 6 4 5 6 4
RAVLT, total immediate recallz 20 6 7 21 6 9 19 6 8* 20 6 8 20 6 9
RAVLT, delayed recallz 2 6 2 2 6 2 1 6 2 1 6 2 2 6 2
Language score, pt; mean 6 SD
VAT naming 11 6 1 11 6 2 11 6 2 11 6 2 11 6 2
Category fluency 12 6 5 12 6 5 11 6 6 12 6 6 11 6 6
Letter fluency 24 6 11 24 6 11 24 6 12 24 6 12 24 6 12
Visuospatial functioning score, pt; mean 6 SD
Incomplete letters 14 6 5 14 6 6 14 6 7* 14 6 6 13 6 6
Dot counting 9 6 1 9 6 2 9 6 1 9 6 1 9 6 2
Number location 8 6 2 8 6 2 8 6 2 8 6 2 7 6 2
Executive functioning score, pt; mean 6 SD
TMT Bx 270 6 208 274 6 135 268 6 128 264 6 138 280 6 122
Digit span backward 6 6 3 6 6 3 6 6 3 6 6 3 6 6 2*
Attention score, pt; mean 6 SD
TMTAx 106 6 62 107 6 77 106 6 73 101 6 74 113 6 76
Digit span forward 10 6 3 11 6 3 10 6 3* 10 6 3 11 6 3
Abbreviations:MTA,medial temporal lobe atrophy; PA, parietal atrophy; SD, standard deviation;MMSE,Mini-Mental State Examination; CAMCOG, Cam-
bridge Cognitive Examination; VAT, Visual Association Test; RAVLT, Rey Auditory Verbal Learning Task; TMT, Trail Making Test.
NOTE. Two-way analyses of variance were performed with MTA and PA as a between-subject factor. Gender, age, and education were entered as covariates.
*P , .05.
yAccording to the Verhage system.
zDutch version of the RAVLT.
xHigher scores imply worse performance.
L.L. Smits et al. / Alzheimer’s & Dementia 10 (2014) S299–S305 S301or absent based on a mean score for left and right of 1.5
points or more.2.4. Statistical analysis
Because complete case analysis (exclusion of all patients
with one or more missing neuropsychological tests) leads
to loss of statistical power and biased results, we imputed
the data [27,28]. There was variance in the number of
completed neuropsychological tests. On average, every test
was completed by 260 patients, ranging from 306 (digit
span forward) to 148 (TMT B). Tests were not finished
because of cognitive impairment or lack of time. We used
the software package Multivariate Imputation by Chained
Equations (version 2.14.1 [29]) in the statistical program R
(version 3.0.0) to perform multiple imputations of the data.
Briefly, this method uses fully conditional specification,
which constructs multivariate imputation models with a set
of conditional densities for each variable. Age, gender, and
education level were included as predictor variables in addi-
tion to the neuropsychological test scores for imputation of
the missing values.
We report pooled statistics over five imputed data sets.
PASWStatistics 18.0 forMac was used. TMTA and B scoreswere log-transformed because they were not distributed
normally. All neuropsychological data were standardized
into z scores to allow comparison of different neuropsycho-
logical tests within patients. TMT A and B scores were
inverted by computing21! z score, because higher scores
imply a worse performance. For each of the five cognitive
domains, the mean z scores for the corresponding tests
were calculated. Independent sample t tests and c2 tests
were conductedwhen appropriate. To assess the relationships
between MTA and PA and cognitive functions, we used two-
way analyses of variance (ANOVA), with MTA and PA as
independent variables, and composite domain scores as de-
pendent variables. Gender, age, and education were entered
as covariates. When there were no significant interactions,
pooled P values were derived from the model without inter-
action terms. We repeated the two-way ANOVA after strati-
fication based on age at diagnosis: early-onset AD (65 years
or younger) and late-onset AD (older than 65 years). For all
analyses, the significance level was set at P , .05.
3. Results
In the total sample, age (mean 6 standard deviation) was
67 6 8 years, and 175 patients (53%) patients were female
(see Table 1 for demographics). Mean MMSE score was
Fig. 1. Illustrative magnetic resonance images (coronal T1 and axial fluid-attenuated inversion recovery) of four patients with Alzheimer’s disease and com-
parably mild dementia (Mini-Mental State Examination score for all patients was 23 points). (A) Patient with both medial temporal lobe atrophy (MTA) and
posterior atrophy (PA). This 77-year-old woman visited our memory clinic for a second opinion. Neuropsychological assessment revealed impairment of mem-
ory and visuospatial functioning, and some executive impairment, including impaired flexibility. On magnetic resonance imaging (MRI), MTA grade 2 (both
hemispheres) and PA grade 2 (both hemispheres) were seen. Also, a Fazekas score of 2 points was noted. (B) Patient with MTA in absence of PA. This 78-year-
old man visited our memory clinic and reported memory complaints and difficulties with word finding for the past 3 years. Neuropsychological assessment
showed clear impairments in memory and word finding, and some limitations in the other cognitive domains. MRI showed MTA grade 4 (both hemispheres),
no PA, and some punctate white matter abnormalities. (C) Patient with PA in the absence of MTA. This 57-year-old woman visited our memory clinic for a third
opinion. Earlier investigations did not yield a diagnostic conclusion. She was not able to work anymore because of her memory complaints. Her husband re-
ported additional troubles with word finding and attention; nevertheless, she could function on her own. Neuropsychological assessment showed impairment in
memory and visuospatial functioning. On MRI, major PA and atrophy of the precuneus and posterior cingulate were seen. The medial temporal lobes also
showed mild atrophy (both hemispheres, grade 1). (D) Patient with no atrophy. This 62-year-old man visited our memory clinic for further research regarding
his cognitive complaints of forgetfulness and difficulty reading digital clocks. Neuropsychological assessment found impairments in memory, language, and
executive functioning. MRI showed no abnormalities, with the exception of minimal PA. Additionally, a Pittsburgh compound B positron emission tomographic
scan showed amyloid depositions and in the cerebrospinal fluid, decreased amyloid b and slightly increased tau was observed.
L.L. Smits et al. / Alzheimer’s & Dementia 10 (2014) S299–S305S302206 5 points andmean CAMCOG scorewas 666 17 points.
Based on dichotomized MRI ratings, 84 subjects (26%) had
both MTA and PA, 98 (30%) had MTA only, 57 (17%) had
PA only, and 90 (27%) had no atrophy. Fig. 1 shows examples
of patients with these specific atrophy patterns, all with com-
parably mild dementia (MMSE score, 23 points).
In total, 85 subjects completed all neuropsychological
tests, and 244 patients missed at least one test. There was
no difference in gender distribution between these two groups
(complete, 49% female; missing, 55% female; P5 .49), nor
was there a difference in age (complete, 68 6 7 years; mis-
sing, 67 6 8 years; P 5 .35). The complete group had
a slightly higher level of education than the incomplete group
(complete, level of education 5.26 1.2; missing, level of ed-
ucation 4.76 1.3;P5 .001). The complete group had less se-
vere cognitive impairment, as evidenced by higher MMSE
scores, than the missing group (complete, 23 6 3 points;
missing, 19 6 5 points). Regarding MRI, both groups had
comparable presence of MTA (complete, 55%; missing,
55%; P 5 1.0), and people with missing values were more
likely to have PA (complete, 32%; missing, 46%; P 5 .04).
Table 1 also shows the raw neuropsychological test results ac-
cording to presence of MTA and PA. Patients with MTA per-
formed worse on total immediate recall of the Dutch RAVLT
(P,.05), incomplete letters (P,.05), and digit span forward(P , .01) than patients without MTA. Patients with PA per-
formed worse on digit span backward than patients without
PA (P , .01). Regarding other cognitive tests, we found no
differences between patients with or without MTA, or pa-
tients with or without PA.
Subsequently, we used two-way ANOVA to assess the
combined effects of MTA and PA on functioning in cognitive
domains, with gender, age, and education as covariates. There
were no significant interactions betweenMTA and PA. There-
fore, pooledP values were derived frommodelswithout inter-
action terms. We found that patients with MTA performed
worse onmemory (P, .01), language (P, .05), and attention
(P, .05) comparedwith patients withoutMTA. Therewas no
relation betweenMTA and visuospatial functioning (P5 .12)
or executive functioning (P 5 .24). Patients with PA per-
formed worse on visuospatial functioning (P, .05) and exec-
utive functioning (P , .05) compared with patients without
PA. There was no relation between PA and memory
(P5 .67) or language (P5 .19). Fig. 2 illustrates that, accord-
ing to presence ofMTA and/or PA, groups show different cog-
nitive profiles; patients with no atrophy showed relatively less
impaired performance in comparison with the other groups.
Patients with MTAwere most impaired on memory. Patients
withPAshowed relatively goodmemoryand performedworse
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neuropsychological testing compared with other groups,
with most prominent impaired performance on language,
visuospatial functioning, and attention.
Next, we stratified the analysis for age, creating two
groups: early-onset AD (n 5 156) and late-onset AD (n 5
173). Table 2 shows the demographics of both groups.
Patients with early-onset AD performed worse on the
MMSE and the CAMCOG than patients with late-onset
AD. Patients with late-onset AD had more severe MTA
than early-onset patients. The degree of PA in patients with
early-onset AD, however, was just as severe as in those
with late-onset AD. In early-onset AD, there was no relation
between MTA and any cognitive domain. The performance
of patientswith early-onset ADwith PA onvisuospatial func-
tioning tended to be worse than younger patients without PA
(P5 .055). We did not find any other relation with PA in pa-
tients with early-onset AD, nor were there any interactions
between MTA and PA. In late onset AD, patients with
MTA performed worse on memory (P , .01), language
(P , .05), visuospatial functioning (P , .05), and attention
(P, .01) than older patients without MTA. There was no re-
lation between MTA and executive functioning, nor was
there a correlation between PA and cognitive functioning.
There were no interactions between MTA and PA in patients
with late-onset AD.Cognitive domains
Fig. 2. Mean neuropsychological z scores according to medial temporal
lobe atrophy (MTA) and parietal atrophy (PA). The x-axis shows the five
cognitive domains: memory, language, visuospatial functioning, executive
functioning, and attention. (A) Mean z scores for patients with no MTA
(gray bars, n 5 147) compared with patients with MTA (black bars,
n 5 182; upper panel). (B) Mean z scores for patients with no PA (gray
bars, n 5 188) and with PA (black bars, n 5 141). We performed two-
way analysis of variance to assess the combined effects of MTA and PA
on functioning in cognitive domains, using gender, age, and education as
covariates. *Significant main effect (P , .05).4. Discussion
Using simple visual rating scales, we showed that MTA
was associated with impaired memory, language, and atten-
tion, whereas PA was associated with impaired visuospatial
functioning and executive functioning. These findings pro-
vide evidence that, despite comparable disease severity, clin-
ical heterogeneity can be related to variability in regional
atrophy in AD.
The visual rating scale for MTA has been used for more
than two decades now in both research and clinical settings
[9,30]. It is increasingly acknowledged that evaluation of
MRI in the context of AD should not be restricted to the
medial temporal lobe. To facilitate use in clinical practice,
we recently developed a visual rating scale for PA, but its
clinical use has not yet been established. We used both
scales in a large cohort of patients with AD, and found that
MTA and PA are both observed frequently, together as well
as in isolation. In our cohort, 17% of patients had PA in
absence of MTA, which is less than in two former studies
in which the numbers were 28% and 30%, respectively
[14,15]. This difference can probably be explained by the
fact that, on average, patients in the current study were
older than in one former study [15], while PA in isolation is
more often observed in younger patients [10–12,31].
The association we found between PA and executive
functioning at first seems rather counterintuitive, but could
be explained in part by worse performance on the TMT B,
which—in addition to measuring executive functioning—also relies heavily on intact visuospatial abilities. Further-
more, atrophy of frontoparietal regions influencing execu-
tive functioning has been demonstrated before [3]. Until
now, only a few studies have been conducted using the PA
scale, showing that the scale seems to discriminate AD
from dementia with Lewy bodies and frontotemporal lobar
degeneration [14]. Furthermore, PA ratings could distin-
guish between younger control subjects and early-onset
AD, but not between older control subjects and late-onset
AD [15]. It has been suggested that in patients with mild cog-
nitive impairment, theMTA and PA scale may offer indepen-
dent and complementary predictive information regarding to
conversion to AD [32]. In the current study, we found that PA
occurs in both early-onset and late-onset AD. Associations
in the stratified analysis were no longer significant, probably
as a result of a lack of power. Our results are in line with
these former findings, showing that ratings on both scales
Table 2
Demographics of patients with early- and late-onset Alzheimer’s disease
Characteristic Early onset Late onset
n 156 173
Women, n (%) 90 (58) 85 (49)
Age, y; mean 6 SD 60 6 4 73 6 5*
Level of education; mean 6 SDy 5 6 1 5 6 1
Mean MTA 6 SD 1.2 6 0.8 1.6 6 0.8*
Mean PA 6 SD 1.3 6 0.8 1.3 6 0.7
MMSE score, pt; mean 6 SD 19 6 5 21 6 5*
CAMCOG score, pt; mean 6 SD 63 6 17 69 6 16*
Abbreviations: SD, standard deviation; MTA, medial temporal lobe atro-
phy; PA, parietal atrophy; MMSE, Mini-Mental State Examination; CAM-
COG, Cambridge Cognitive Examination.
NOTE. Independent sample t tests and c2 tests were performed with onset
as a between-subject factor.
*P , .05.
yAccording to the Verhage system.
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mains, which emphasizes their complementary value.
The visual ratings of MTA and PA are easy to assess,
and the results are in accordance with more sophisticated
methods, such as volumetric MRI or voxel-based mor-
phometry. A study in prodromal AD showed that patients
had mainly MTA, which was associated with severe mem-
ory impairment [5]. Another study in which patients with
AD were divided into typical and atypical subgroups, based
on their neuropsychological performance, found that non-
memory problems in AD were associated with thinning
of the right superior parietal lobe, whereas memory impair-
ment was related to thinning of the left entorhinal cortex
[33]. In addition, in a former study conducted by our
own group, in a completely independent sample, atrophy
of the precuneus was related specifically to impaired visuo-
spatial functioning [11]. A volumetric study found, in AD,
associations between MTA and memory impairment, and
PA and praxis in AD [6].
A possible limitation of this study may be that we did not
have postmortem data available, so the possibility of misdiag-
nosis cannot be ruled out. Nevertheless, we had an extensive
standardizedworkup, and all patients fulfilled core clinical cri-
teria of probable AD. Furthermore, in our neuropsychological
assessment no specific tests for praxis and gnosis were in-
cluded, although these cognitive domains also seems specifi-
cally related to PA. One of the strengths of this study is that
we imputed the missing neuropsychological data. In this
way, we avoided selection bias that would be created by using
only complete neuropsychological assessments. Further
strengths are the large cohort of patients with AD with avail-
able magnetic resonance images, and the standardized neuro-
psychological test battery, including tests assessing
visuospatial functioning.
Benson and colleagues [13] were one of the first to de-
scribe PCA as a very exceptional syndrome. Lately, it has
been suggested that PCA can be considered an independent
nosology, with AD as the most common underlying cause[34]. Our results show that an observation of PA on MRI is
not restricted to the rare and highly specific cases of patients
with PCA. Rather, in the spectrum of AD, PA is a frequently
observed MRI characteristic in both early and late onset.
Furthermore, our results seemingly suggest that PA predis-
poses for specific nonmemory symptoms. These symptoms
are relatively often encountered in patients with early-
onset AD, providing additional relevance for using the visual
rating scale in this group. Our results suggest that the visual
rating scale for PA is a promising diagnostic tool in addition
to the MTA scale, especially when taking into account the
new clinical criteria for AD, which include nonamnestic pre-
sentations as well [4].
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1. Systematic review: The heterogeneity of AD, that
goes beyond clinical presentation, asks for new diag-
nostic tools. PubMed was used for literature search.
Studies solely including patients with ADwere prior-
itized. No previous cross-sectional study assessing
visual rating scales for medial temporal lobe atrophy
(MTA) and parietal atrophy (PA) in association with
cognitive impairment in patients with AD was iden-
tified.
2. Interpretation: The recently developed MRI scale to
visual rate PA is easy to use in clinical practice.
This is a promising tool; we found that many patients
with AD show PA, while their medial temporal lobe
is still relatively unharmed. We show that MTA and
PA are related to impairment in specific cognitive
functions, providing validation of the scale.
3. Future directions: Future research should attempt to
1) further correlate the PA rating scale with clinical
heterogeneity 2) investigate the associations between
pattern of atrophy and cognition longitudinally to
achieve better understanding of the heterogeneity in
the spectrum of AD 3) validate the scale in other
forms of dementia e.g. Dementia with Lewy bodies.
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